Publications

Publications About Diabetology

  • Benhalima K, Polsky S. Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes. Journal of Diabetes Science and Technology 2025. https://pubmed.ncbi.nlm.nih.gov/40071788/

  • Healy AM, Shubrook JH; Double Diabetes: A Clinical Challenge. Clin Diabetes 2024; cd240025. https://doi.org/10.2337/cd24-0025.

  • Shubrook JH, Ramirez BF, Healy AM, Salzberg L, Ahmed S, Feinberg H, Schutta M, Schwartz FL, anc Low Wang CC. Primary Care Diabetes Fellowship Programs Developing Standards. Clinical Diabetes. 2020. https://doi.org/10.2337/cd20-0055

  • Healy AM, Shubrook JH, Feinberg H, Ahmed S. The necessary evolution of diabetes fellowships in the United States. Postgraduate Medicine. 2021. https://doi.org/10.1080/00325481.2021.1894055

  • Salzberg L, Shubrook JH. Primary Care Diabetes Fellowships: Preparing the Future Primary Care Physician Workforce. Fam Med. 2020;52(10):765-766. DOI: 10.22454/FamMed.2020.996607

  • Draznin B, Sadhu A, Schutta M, Ramirez BF, Polsky S, Shubrook JH, Low Wang CC. The Diabetes Epidemic and the Diabetes Fellowships for Primary Care Physicians. Endocrine Practice. 2021. DOI: https://doi.org/10.1016/j.eprac.2021.03.007

  • Healy AM, Shubrook JH, Schwartz FL, Cummings DM, Drake AJ 3rd, and Tanenberg RJ. Endocrinologist opinions of Diabetology as a Primary Care Subspecialty. Clinical Diabetes. 2018. https://doi.org/10.2337/cd17-0097

  • Healy AM, Tanenberg RJ, Schwartz FL, Shubrook JH. Diabetes Fellowship in Primary Care: A Survey of Graduates. Journal of Osteopathic Medicine. 2018 https://doi.org/10.7556/jaoa.2018.122

  • Sadhu AR, Healy AM, Patil SP, Cummings DM, Shubrook JH,and Tanenberg RJ. Time is Now: Diabetes Fellowships in the United States. Current Diabetes Reports: 2017 DOI: 10.1007/s11892-017-0936-6

  • Tanenberg, R J; Cummings DM; Springer-Dreyfus, K.; Newton, CA; Drake, AJ 3rd and Lewis, MJ: Primary Care Fellowship in Diabetes: An Innovative Program in Post Graduate Diabetes Education: Teaching and Learning in Medicine: An International Journal: 2009, Oct: 21(4), 334-343 DOI: 10.1080/10401330903228703

  • Tanenberg RJ. The Diabetes Specialist--An "Endangered Species". Diabetes Forecast. 2002

  • Writing Committee Members; Ndumele CE, Rodriguez F, Dixon DL, Khan SS, Mukherjee D, Bajaj M, Bangalore S, Bozkurt B, Breathett K, Clarke SL, de Boer IH, Ellison DH, Evangelista LS, Heffron SP, Kazi DS, Kulshreshtha A, Lingvay I, Low Wang CC, Mercado CA, Morton JM, Neeland IJ, Pagidipati N, Powell-Wiley TM, Rangaswami J, Rao G, Reza N, Saeed A, St Peter W, Starks JB, Sterling M, Talbot AW, Tran AH, Tuttle KR, VanWagner LB, Vest AR, Virani SS. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Jul 28;154(4):e50-e158. doi: 10.1161/CIR.0000000000001453. Epub 2026 Jun 9. PMID: 42263157.

  • Ndumele CE, Rodriguez F, Dixon DL, Khan SS, Mukherjee D, Bajaj M, Bangalore S, Bozkurt B, Breathett K, Clarke SL, de Boer IH, Ellison DH, Evangelista LS, Heffron SP, Kazi DS, Kulshreshtha A, Lingvay I, Low Wang CC, Mercado CA, Morton JM, Neeland IJ, Pagidipati N, Powell-Wiley TM, Rangaswami J, Rao G, Reza N, Saeed A, St Peter W, Starks JB, Sterling M, Talbot AW, Tran AH, Tuttle KR, VanWagner LB, Vest AR, Virani SS. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Jun 9;87(22S):e1889-e2007. doi: 10.1016/j.jacc.2026.03.056. PMID: 42265997; PMCID: PMC13399222.

  • Khan SS, Bhave N, Blumenthal RS, Coresh J, Huang X, Joseph JJ, Khera A, Ho JE, Lloyd-Jones DM, Low Wang CC, Lu Y, Morris PB, Nasir K, Natarajan P, Rangaswami J, Rodriguez F, Sperling LS, Virani SS, Zhang S, Ndumele CE; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Hypertension; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; American College of Cardiology. Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2026 Jul 28;154(4):e159-e180. doi: 10.1161/CIR.0000000000001447. Epub 2026 Jun 9. PMID: 42263147.

  • Samson SL, Vellanki P, Blonde L, Hirsch IB, Hoang TD, Isaacs SD, Izuora KE, Low Wang CC, Ooi CP, Padilla BI, Schulman-Rosenbaum R, Twining CL, Umpierrez GE, Valencia WM. American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update. Endocr Pract. 2026 Apr;32(4):473-518. doi: 10.1016/j.eprac.2026.01.006. Epub 2026 Mar 17. Erratum in: Endocr Pract. 2026 Aug;32(8):1332. doi: 10.1016/j.eprac.2026.05.025. PMID: 41842862.

  • Wright EE Jr, Low Wang CC, Novak LM, Shubrook JH. Misclassification of type 1 diabetes as type 2 diabetes in adults: practical guidance for screening and diagnosis for primary care providers. Postgrad Med. 2026 May;138(4):396-407. doi: 10.1080/00325481.2026.2672192. Epub 2026 May 18. PMID: 42152488.

  • Ebekozien O, ..Shubrook JH….Wright E. Diabetes Technology in the Primary Care Setting: An ADA Scientific Statement. Diabetes, Obesity, and CardioMetabolic CARE 2026; doci260005

  • Ilyev J, Neumann T, Dowling T, Shubrook JH. Practice-Based Learning and Improvement – How much time do Internal Medicine Residents spend supplementing patient care with outside resources? JOM Accepted 9/2026.

  • Lam E, Shubrook J. Primary Care Approaches to Metabolic Dysfunction–Associated Steatotic Liver Disease in Type 2 Diabetes. J Osteopath Fam Physicians Calif. 2026;5(3). doi:10.58858/050301

  • Meza-Torres, … Jay H Shubrook, ..et al. Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus. The Lancet Primary Care, 2026,100205,ISSN 3050-5143,https://doi.org/10.1016/j.lanprc.2026.100205.

  • Galindo RJ, Soliman D, Neumiller JJ, Shubrook JH, Tuttle KR. Managing chronic kidney disease according to KDIGO risk categories: A primer for primary care. Cleve Clin J Med. 2026;93(6):353-365. Published 2026 Jun 1. doi:10.3949/ccjm.93a.25072

  • Nijjar A, Bains Y, Shubrook JH. A clinician’s guide to diagnosing and managing T2D in South Asians. Accepted to DOC care- May 2026.

  • Dongmo Fotsing, L et Shubrook JH. Renal Replacement Therapy: Current Modalities, Indications, and Clinical Considerations. Accepted to Postgraduate Medicine May 2026. PMID: 42456013.

  • Wright, E. E., Jr., Low Wang, C. C., Novak, L. M., Shubrook, J. H. (2026). Misclassification of type 1 diabetes as type 2 diabetes in adults: practical guidance for screening and diagnosis for primary care providers. Postgraduate Medicine, 138(4), 396–407. https://doi.org/10.1080/00325481.2026.2672192.

  • Shubrook JH, Karandrea S, Longo N, Welch L, Bretartner. Real-World Impact of an Immersive Continuing Education Initiative on Screening for Type 1 Diabetes. Accepted to Diabetes and Clinical Research May 2026. ISSN: 2689-2839

  • Cui, CL, Shubrook JH, Pena N. An Osteopathic Perspective on Managing Metabolically Dysfunctional-Associated Steatotic Liver Disease (MASLD). Accepted to AAO June 2026.

  • Kanwal F, Bril F, Wai-Sun Wong V, Adams LA, Pfotenhauer K, Skolnik N, Wright EE Jr, Eckel RH, Noureddin M, Loomba R, Allen AM, Bansal MB, Godwin KM, El-Serag HB, Shubrook JH. Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology. 2026 Mar 9:S0016-5085(26)00198-8. doi: 10.1053/j.gastro.2026.01.047. Epub ahead of print. PMID: 41812830.

  • Younossi et al. Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver Disease, Accepted in Clinical Gastroenterology and Hepatology 4.1.2026. PMID: 41950980

  • Young CF, O’Brien K, Neumiller JJ, Isaacs D, Shubrook JH, Clements JN; The Critical Role of Diabetology Pharmacists in Improving Cardiovascular-Kidney-Metabolic Care and Outcomes. DOCM CARE 11 February 2026; 1 (1): 147–152. https://doi.org/10.2337/doc25-0049

  • Lazarus JV, et MASLD/MASH Collaborators. Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study. Lancet Gastroenterol Hepatol. 2026 Mar;11(3):232-242. doi: 10.1016/S2468-1253(25)00300-0. Epub 2025 Dec 13. PMID: 41397405.

  • Ainscow C, Kahlon U, Shubrook JH, Belec M. Unmet need for Evidence for Pediatric Diabetes Prevention Programs Journal of Osteopathic Pediatrics (JOOP). March 2026.